The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Current Status of Benzodiazepines
Abstract
Clinical Use of BenzodiazepinesAnxietySince 1977, several new benzodiazepines have been marketed in the United States for the treatment of anxiety syndromes67 68 69 70 71 (Table 1). These drugs may offer some subtle clinical options. Prazepam, for example, may cause less drowsiness after single doses than do comparable doses of other benzodiazepines because of the slow appearance of desmethyldiazepam in the blood.72 Some clinical studies suggest a reduced incidence of sedation during treatment with lorazepam and alprazolam — benzodiazepines that have an intermediate half-life — possibly because the extent of drug accumulation is reduced; however, this is not a consistent finding.69 , 70 In . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
Benzodiazepine withdrawal symptoms and propranolol
TYRER, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92861-0 · Cited by 297
Chouinard, G., Annable, L., Fontaine, R., & Solyom, L. (1982) · Psychopharmacology · doi:10.1007/bf00464571 · Cited by 256
Rebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680119 · Cited by 197
Self-citationGreenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710227 · Cited by 134
Self-citationKoch-Weser, J., & Browne, T. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810122991505 · Cited by 106
Self-citationNitrazepam: lastingly effective but trouble on withdrawal.
Adam, K., Adamson, L., Brezinova, V, & Hunter, W. M. (1976) · BMJ · doi:10.1136/bmj.1.6025.1558 · Cited by 90
Quazepam and flurazepam: Long-term use and extended withdrawal
Kales, A., Bixler, E. O., Soldatos, C. R., Vela-Bueno, A., Jacoby, J., & Kales, J. D. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.236 · Cited by 62
BIXLER, E. O., KALES, A., SOLDATOS, C. R., SCHARF, M. B., & KALES, J. D. (1978) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1978.tb02430.x · Cited by 60
Cited by
The Nature of Recollection and Familiarity: A Review of 30 Years of Research
Yonelinas, A. P. (2002) · Journal of Memory and Language · doi:10.1006/jmla.2002.2864 · Cited by 3,840
Rickels, K. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290060008 · Cited by 384
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Use of benzodiazepines in anxiety disorders
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281907 · Cited by 341
Self-citationUpdate on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Metadata
- Authors
- Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1983-08-18
- Volume
- 309
- Issue
- 7
- Pages
- 410-416
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3214709855
- Cited by
- 451
- References
- 11
- FWCI
- 36.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Status of Benzodiazepines. https://app.cochat.ai/papers/10.1056/nejm198308183090705
- The paper
- Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983). Current Status of Benzodiazepines. New England Journal of Medicine. https://doi.org/10.1056/nejm198308183090705
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
